Preferred Drug List
The Preferred Drug List is a medication list recommended to the Bureau for Medical Services by the Medicaid Pharmaceutical and Therapeutics (P & T) Committee and approved by the Secretary of the Department of Health and Human Resources, as authorized by West Virginia Code §9-5-15. The drugs which are indicated as "preferred" have been selected for their clinical significance and overall efficiencies.
All Medicaid-covered drugs noted as "non-preferred" will continue to be available through the prior authorization process. Some select preferred drugs may require prior authorization, as noted. A three-day emergency supply of prior-authorized drugs can be dispensed by a pharmacy until authorization is completed.
Please note: The PDL only addresses certain drug classes. Some classes of drugs will not be reviewed for preferential agents because of no or limited cost savings.
Therefore, drugs which have historically been covered by Medicaid and are not listed on the Preferred Drug List will contiue to be covered.
New drugs introduced into the marketplace in therapeutic classes that have been reviewed will be considered non-preferred until the annual review of the particular therapeutic class. Exceptions to this policy will be made for drugs which the FDA has given priority status.
BMS contracts with Magellan Medicaid Administration, Inc. (MMA) for assistance with PDL development and clinical support. BMS is also a member of the Sovereign States Drug Consortium (SSDC), the only state administered multi-state supplemental rebate pool. For more information about MMA or SSDC, please refer to their websites at, http://www.rxssdc.org respectively.
PDL Frequently Asked Questions
P & T Committee Mission Statement
The West Virginia Medicaid Pharmaceutical and Therapeutics Committee is committed to:
- Objectively recommending drugs for inclusion on the WV Preferred Drug List (PDL) that are effective and cost efficient, while providing maximum safety;
- Examine the scientific literature (found in labeling, drug compendia, and peer reviewed clinical literature) for sound clinical evidence that supports selecting specific drugs to be included on the PDL
- Ensure that the PDL provides for medically approriate drug therapies for use in the general Medicaid population, allowing healthcare providers to care for the majority of their patients without a prior authorization request.
PREFERRED DRUG LISTS
|
|
Effective Date |
Posted Date |
|
| |
April 12, 2012 |
April 17, 2012 |
| |
April 1, 2012 |
March 2, 2012 |
| |
January 1, 2012 |
February 6, 2012 |
| |
January 1, 2012 |
December 2, 2011 |
| |
October 1, 2011 |
October 3, 2011 |
| |
October 1, 2011 |
September 2, 2011 |
| |
July 1, 2011 |
June 10, 2011 |
| |
April 1, 2011 Cough/Cold NDC List (update) |
April 1, 2011 |
| |
April 1, 2011 |
March 25, 2011 |
| |
April 1, 2011 |
March 11, 2011 |
|
| |
April 1, 2011 |
March 4, 2011 |
| |
January 1, 2011 |
February 25, 2011 |
|
| |
January 1, 2011 |
December 29, 2010 |
|
| |
January 1, 2011 |
December 1, 2010 |
|
| |
October 1, 2010 |
October 22, 2010 |
|
| |
October 1, 2010 |
September 1, 2010 |
|
| |
August 10, 2010 |
August 10, 2010 |
|
| |
August 1, 2010 |
July 30, 2010 |
|
| |
August 1, 2010 Cough/Cold NDC List |
July 30, 2010 |
|
|
| |
July 1, 2010 |
June 1, 2010 |
|
| |
April 1, 2010 |
May 5, 2010 |
|
| |
April 1, 2010 |
April 16, 2010 |
|
| |
April 1, 2010 |
March 29, 2010 |
|
| |
April 1, 2010 |
March 10, 2010 |
|
| |
January 1, 2010 Vitamin D NDC List |
December 2, 2009 |
|
|
| |
January 1, 2010 |
December 2, 2009 |
|
| |
October 1, 2009 |
September 25, 2009 |
|
| |
July 1, 2009 |
June 5, 2009 |
|
| |
July 1, 2009 Cough/Cold NDC List |
June 5, 2009 |
|
|
| |
July 1, 2009 Prenatal Vitamin NDC List |
June 5, 2009 |
|
|
| |
June 1, 2009 |
June 5, 2009 |
|
| |
April 1, 2009 |
March 5, 2009 |
|
| |
January 1, 2009 |
November 26, 2008 |
|
| |
November 3, 2008 |
October 20, 2008 |
|
| |
September 2, 2008 |
August 29, 2008 |
|
| |
August 11, 2008 |
August 8, 2009 (Criteria Changes) |
|
| |
July 1, 2008 |
June 16, 2008 |
|
| |
April 1, 2008 |
April 7, 2008 (Criteria Changes) |
|
| |
April 1, 2008 |
March 28, 2008 (Criteria Changes) |
|
| |
April 1, 2008 |
March 4, 2008 |
|
| |
October 1, 2007 |
November 13, 2007 (Drug List) |
|
| |
October 1, 2007 |
October 26, 2007 (Drug List) |
|
| |
October 1, 2007 |
October 2, 2007 (Criteria Changes) |
|
| |
October 1, 2007 |
October 1, 2007 (Criteria Changes) |
|
| |
October 1, 2007 |
September 18, 2007 (Drug List) |
|
| |
October 1, 2007 |
September 12, 2007 |
|
| |
July 9, 2007 |
August 7, 2007 (Criteria Changes) |
|
| |
July 9, 2007 |
June 25, 2007 (Drug List) |
|
| |
April 2, 2007 |
June 13, 2007 (Drug List) |
|
| |
April 2, 2007 |
March 15, 2007 |
|
| |
October 2, 2006 |
March 16, 2007 (Criteria Change) |
|
| |
October 2, 2006 |
January 19, 2007 (Drug List) |
|
| |
October 2, 2006 |
November 20, 2006 (Drug List) |
|
| |
October 2, 2006 |
October 27, 2006 (Criteria Change) |
|
| |
October 2, 2006 |
October 2, 2006 |
|
| |
April 1, 2006 |
April 1, 2006 |
|
| |
October 3, 2005 |
November 22, 2005 |
|
| |
October 3, 2005 |
November 10, 2005 |
|
| |
July 1, 2005 |
July 6, 2005 |
|
| |
July 1, 2005 |
June 29, 2005 |
|
| |
July 1, 2005 |
June 6, 2005 |
|
| |
April 1, 2004 |
Phase VIII Tabled |
|
| |
April 1, 2004 |
Phase VIII DUR |
|
| |
November 1, 2003 |
October 29, 2003 |
|
| |
November 1, 2003 |
Phase VII |
|
| |
August 15, 2003 |
Phase VI |
|
| |
May 1, 2003 |
Phase V |
|
| |
April 9, 2003 |
Phase IVa |
|
| |
April 9, 2003 |
April 7, 2003 |
|
| |
March 5, 2003 |
Phase III |
|
| |
February 1, 2003 |
Phase IV |
|
| |
January 13, 2003 |
Phase I |
|
| |
January 7, 2003 |
March 31, 2003 |
|
| |
December 1, 2002 |
Phase II |
|